3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Ovarian Neoplasms
8
Breast Neoplasms
8
Carcinoma, Ovarian Epithelial
4
Carcinoma, Non-Small-Cell Lung
4
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Unresectable Stage III NSCLC
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thrombocytopenia
1
Primary Breast Cancer
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Ovarian Diseases
1
Neutropenia
1
Neoplasms, Unknown Primary
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Interventions
Gemcitabine
9
Carboplatin
8
Paclitaxel
7
Capecitabine
7
Irinotecan
6
pembrolizumab
3
Radiotherapy
3
Oxaliplatin
3
Fluorouracil
3
Filgrastim
3
Cisplatin
3
Bevacizumab
3
etoposide phosphate
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Genetic Testing
2
FAPI-46
2
Etoposide
2
Erlotinib Hydrochloride
2
Docetaxel
2
Cyclophosphamide
2
Amifostine
2
Albumin-Bound Paclitaxel
2
tislelizumab
1
tegafur-gimeracil-oteracil
1
spartalizumab
1
sintilimab
1
erythromycin propionate-N-acetylcysteinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Unknown Primary
×
CP protocol
×
Clear all
NCT00894569
2009-05-14
PACET-CUP
Heidelberg University
Phase 2
Unknown
150 enrolled